NICOTINE

Product NDC
58602-903
11-digit product format
586020903
Labeler code
58602
Product ID
58602-903_dcc0b057-3d5e-4aeb-ac31-478d7a2f47fa
Type
HUMAN OTC DRUG
Nonproprietary name
NICOTINE POLACRILEX
Dosage form
LOZENGE
Route
ORAL
Labeler
Aurohealth LLC
Application
ANDA213266
Marketing category
ANDA
Marketing start
2022-06-24
Substance
NICOTINE
Active strength
2 mg/1
Pharmacologic classes
Cholinergic Nicotinic Agonist [EPC], Nicotine [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213266-001NICOTINE POLACRILEXNICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03
A213266-002NICOTINE POLACRILEXNICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 70 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-0384e616aacf4f…
2026-09-14 22:38:342026-08A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-0384e616aacf4f…
2026-08-18 06:07:402026-07A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03caaa826d4ba7…
2026-08-18 06:07:402026-07A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03011fe1cb6892…
2026-02-19 14:30 UTC2026-02A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-0331067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-0331067a03dcf5…
2025-08-23 18:47 UTC2025-08A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-036a471c1ec25d…
2025-08-23 18:47 UTC2025-08A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-036a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-0303ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-0303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-032680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-032680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-035bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-035bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03d06236e962d9…
2024-10-29 15:01 UTC2024-10A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-0379d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-0379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-031e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-031e350fbaab3a…
2024-05-31 18:47 UTC2024-05A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-038072bd15b7f6…
2024-05-31 18:47 UTC2024-05A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-038072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-035c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-035c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-035d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-035d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-034b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-034b0b4de00fa7…
2022-03-09 01:35 UTC2022-03A213266-001NICOTINE POLACRILEXEQ 2MG BASETROCHE/LOZENGE / ORAL2021-08-03bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A213266-002NICOTINE POLACRILEXEQ 4MG BASETROCHE/LOZENGE / ORAL2021-08-03bb7c543d1eb4…

Additional Listing Data#

Finished product
Yes
Brand name base
NICOTINE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NICOTINE2 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
6M3C89ZY6RInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
359817Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
dcc0b057-3d5e-4aeb-ac31-478d7a2f47faAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dbebfdf8-6e0c-cfa8-fdbc-e5d7f1bf1562Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58602-903-07NICOTINE1 in 1 CARTONLOZENGE11
58602-903-07NICOTINE24 in 1 CONTAINERLOZENGE241
58602-903-51NICOTINE24 in 1 CONTAINERLOZENGE241
58602-903-51NICOTINE3 in 1 CARTONLOZENGE31
58602-903-65NICOTINE24 in 1 CONTAINERLOZENGE241
58602-903-65NICOTINE6 in 1 CARTONLOZENGE61

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58602-903NICOTINE (NICOTINE POLACRILEX) LOZENGE [AUROHEALTH LLC]1Current NDC, Legacy NDC, 6 package rows20220626_dcc0b057-3d5e-4aeb-ac31-478d7a2f47fa.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 8 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NICOTINENICOTINE POLACRILEXAurohealth LLCcbf094d4-2357-426d-8205-9b59c332854f2026-06-16WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266
NICOTINENICOTINE POLACRILEXAurohealth LLC56a1c778-fc3b-4848-a7e0-b1e4f0a8fbc22026-06-12WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266
AMAZON BASIC CARE NICOTINE POLACRILEXNICOTINE POLACRILEXAmazon.com Services LLC113e0be9-7edc-4766-e063-6294a90af7522025-05-02WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266
AMAZON BASIC CARE NICOTINE POLACRILEXNICOTINE POLACRILEXAmazon.com Services LLC10ece1fa-f4c2-42ad-e063-6394a90a3a7d2025-05-02WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266
NICOTINENICOTINE POLACRILEXAurohealth LLC810932e0-a982-400a-b43d-b847152f685b2022-06-24WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266
NICOTINENICOTINE POLACRILEXAurohealth LLCdcc0b057-3d5e-4aeb-ac31-478d7a2f47fa2022-06-24WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266
ndc (product): 58602-903
NICOTINENICOTINE POLACRILEXAurohealth LLC1909cf25-bce8-4880-abc6-548d28a7285d2022-03-07WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266
NICOTINENICOTINE POLACRILEXAurohealth LLCfa730ae3-c2b3-4ea4-8e50-f819b205d1682022-03-07WarningsExact identifier
application applno (ANDA): 213266
application number: ANDA213266

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
359817nicotine 2 MG Oral LozengePSNdcc0b057-3d5e-4aeb-ac31-478d7a2f47fa1
359817nicotine 2 MG Oral LozengeSCDdcc0b057-3d5e-4aeb-ac31-478d7a2f47fa1
359817nicotine 2 MG (as nicotine polacrilex 11.1 MG) Oral LozengeSYdcc0b057-3d5e-4aeb-ac31-478d7a2f47fa1
359817nicotine 2 MG TrocheSYdcc0b057-3d5e-4aeb-ac31-478d7a2f47fa1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58602-903-07586020903071 CONTAINER in 1 CARTON (58602-903-07) / 24 LOZENGE in 1 CONTAINER1 container2022-06-240000-00-00NoNoCurrent
58602-903-51586020903513 CONTAINER in 1 CARTON (58602-903-51) / 24 LOZENGE in 1 CONTAINER3 container2022-06-240000-00-00NoNoCurrent
58602-903-65586020903656 CONTAINER in 1 CARTON (58602-903-65) / 24 LOZENGE in 1 CONTAINER6 container2022-06-240000-00-00NoNoCurrent